Shares of Apria, Inc. (NYSE:APR) have received an average rating of “Buy” from the seven analysts that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $31.86.
Several equities analysts recently commented on APR shares. started coverage on Apria in a research report on Wednesday, June 30th. They set a “buy” rating and a $33.00 price target on the stock. Zacks Investment Research raised Apria from a “hold” rating to a “buy” rating and set a $35.00 price target on the stock in a research report on Tuesday, August 10th. Piper Sandler boosted their price target on Apria from $33.00 to $35.00 and gave the stock an “overweight” rating in a research report on Friday, August 6th. The Goldman Sachs Group lowered Apria from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $32.00 to $29.00 in a research report on Monday, July 19th. Finally, Citigroup boosted their price target on Apria from $33.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, August 6th.
NYSE APR opened at $37.16 on Friday. The firm has a market capitalization of $1.31 billion and a P/E ratio of 0.80. Apria has a 1-year low of $20.07 and a 1-year high of $38.47. The company has a debt-to-equity ratio of 215.95, a current ratio of 1.21 and a quick ratio of 1.18. The business’s 50-day simple moving average is $32.37 and its 200-day simple moving average is $29.35.
In other news, EVP Angela Fyfe sold 1,994 shares of the business’s stock in a transaction that occurred on Wednesday, August 18th. The stock was sold at an average price of $35.04, for a total value of $69,869.76. Following the completion of the sale, the executive vice president now directly owns 3,269 shares in the company, valued at approximately $114,545.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark E. Litkovitz sold 2,458 shares of the business’s stock in a transaction that occurred on Friday, September 10th. The shares were sold at an average price of $37.66, for a total value of $92,568.28. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 84,990 shares of company stock worth $3,070,977.
A number of institutional investors and hedge funds have recently modified their holdings of APR. American International Group Inc. bought a new position in Apria during the 1st quarter worth $123,000. BlackRock Inc. bought a new position in Apria during the 1st quarter worth $10,898,000. New York State Common Retirement Fund bought a new position in Apria during the 1st quarter worth $95,000. UBS Group AG bought a new position in Apria during the 1st quarter worth $78,000. Finally, JPMorgan Chase & Co. bought a new position in Apria during the 1st quarter worth $79,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Apria, Inc provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products.
See Also: How analysts view the yield curve
Receive News & Ratings for Apria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apria and related companies with MarketBeat.com's FREE daily email newsletter.